CMS Open Payments · Program Year 2024
Lsi Solutions Inc
Lsi Solutions Inc reported $274,799.22 across General Payments, Research, and Ownership to 1,055 physicians and teaching hospitals across 1,055 transactions.
- $274.8K Above-median payer
- All-tracks total
- 1,055 Above-median volume
- Transactions
- 1,055 Above-median reach
- Recipients
- −$51.5K
- General Payments vs PY2023
Lsi Solutions Inc reported $274,799.22 across all CMS Open Payments tracks (General + Research + Ownership) to 1,055 physicians and teaching hospitals in Program Year 2024 - ranking #908 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $274,799.22, averaging $260.47 per recipient.
Lsi Solutions Inc's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
28/100
Total payments
F
13/100
Transaction volume
F
18/100
Physician reach
F
18/100
Payment type diversity
D
63/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer lsi-solutions-inc Lsi Solutions Inc
$274.8K · #908/1,925 · 0.0% industry · PY2024
- TOT $274.8K
- RANK #908
- SHARE 0.0%
- TXN 1,055
- RCP 1,055
- CAT 5
- GEN $274.8K
- ΔGEN −$51.5K
- TOP1 35.0%
- PY 2024
Volume peers
Nearest volume peer: LKC Technologies, Inc. ($275.7K)
Lsi Solutions Inc sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Lsi Solutions Inc's CMS-reported General Payments decreased by $51.5K (−15.8%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: LSI SOLUTIONS INCPY2023: LSI SOLUTIONS INCPY2024: LSI SOLUTIONS INC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $326,270.87
- PY2024
- $274,799.22
What the Data Shows for Lsi Solutions Inc
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Lsi Solutions Inc that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
Of the 5 general-payment categories charted below, "Grant" is the largest at $96.1K across 2 transactions, 35.0% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Lsi Solutions Inc made 5 types of general payments. "Grant" is the largest category at $96.1K, 35.0% of General Payments.
Lsi Solutions Inc reports 5 general-payment categories - the top three are Grant (35.0%), Compensation for Services Other Than Consulting (21.5%), and Travel and Lodging (15.4%). The remaining 2 categories make up 28.1% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Lsi Solutions Inc divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Grant | $96.1K | 2 | 35.0% |
| Compensation for Services Other Than Consulting | $59.0K | 7 | 21.5% |
| Travel and Lodging | $42.4K | 38 | 15.4% |
| Food and Beverage | $39.0K | 1,005 | 14.2% |
| Royalty or License | $38.3K | 3 | 13.9% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $223,748.36 (81.4%) of $274,799.22 in this company's General Payments records across 703 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Lsi Solutions Inc
The five named recipients with the highest reported General Payments from this company
- 1
Strong Memorial Hospital
$96,085.00 across 2 reported transactions
- 2
Steven Douglas Mccarus
$41,272.84 across 4 reported transactions
- 3
Michael P Defrain
$38,710.86 across 28 reported transactions
- 4
Andrea Berecz-Prewitt
$24,036.01 across 14 reported transactions
- 5
Tyler Thomas Reed
$23,643.65 across 14 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Lsi Solutions Inc's spend rank (#908 of 1,925, top 47% by spend) and concentration rank (#784 of 1,838, top 43% most concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Orchard Therapeutics North America : $14.0K total payments, HHI 1853
- Zest Holdings, LLC : $571.1K total payments, HHI 1849
- Turing Medical Technologies : $128.3K total payments, HHI 1844
- Hartmann USA, Inc. : $45.9K total payments, HHI 1833
- Arrow International, Inc. : $376.6K total payments, HHI 1833
- Current Health Inc. : $10.2K total payments, HHI 1822
- Lsi Solutions Inc (this company) : $274.8K total payments, HHI 1813
- Photocure Inc : $179.4K total payments, HHI 1810
- LeMaitre Vascular, Inc. : $311.5K total payments, HHI 1805
- RMC Orthopedic & Surgical, Inc. : $13.5K total payments, HHI 1800
- NS Pharma, Inc. : $103.1K total payments, HHI 1796
- Avid Radiopharmaceuticals, Inc. : $8.1K total payments, HHI 1793
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Lsi Solutions Inc's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Lsi Solutions Inc.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Lsi Solutions Inc.
Showing 6 of 1,924 companies with CMS-reported payment data.
B. Braun Interventional Systems Inc.
Bard Access Systems, Inc.
Sonavex, Inc.
Corentec America,Inc.
Joint Restoration Foundation, Inc.
Put this to use
Lsi Solutions Inc ranks #908 of 1,925 by all-tracks total payments, led by "Grant".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Grant" spend across every manufacturer, not just Lsi Solutions Inc. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.